Funding for this research was provided by:
FSBIU VILAR (0576-2019-0009)
Received: 25 June 2020
Accepted: 9 December 2020
First Online: 13 January 2021
: The study protocol has been approved by the VILAR Ethical Committee on Animal Experimentation and carried out per the “European Convention for the Protection of Vertebrate Animals Used for Experimental and other Scientific Purposes (ETS 123). Strasbourg, 1986”. The VILAR biomedical clinic guarantees strict compliance with regulations established by the “Standard Operation Procedures for the Research” and “Sanitary-epidemiological Rules on the Equipment and Maintenance of the Experimental biological clinics (vivarium).”
: Not applicable.
: We declare that Drs. Job and Enioutina are Associate Editors for BMC Pharmacology and Toxicology. We declare that Dr. Catherine M. Sherwin is a Section Editor for Clinical Pharmacology for the BMC Pharmacology and Toxicology journal. All other authors declare that they have no competing interests.